Description:
NSABP PROTOCOL B-35: FOLLOW-UP FORM Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A057E605-C97E-3E81-E034-080020C9C0E0
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A057E605-C97E-3E81-E034-080020C9C0E0Keywords:
Versions (2)
- 8/26/12 8/26/12 -
- 3/23/15 3/23/15 - Martin Dugas
Uploaded on:
August 26, 2012
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Breast Cancer NCT00053898 Follow-Up - NSABP PROTOCOL B-35: FOLLOW-UP FORM - 2034205v3.0
Form F35 Submit every 6 months for the first 5 years, every 12 months thereafter, and when a protocol event occurs.
- StudyEvent: NSABP PROTOCOL B-35: FOLLOW-UP FORM